FDA bans Red No. 3, artificial coloring used in beverages, candy and other foods

FDA bans Red No. 3, artificial coloring used in beverages, candy and other foods


Red Dye # 3 can have deleterious health effects. The cherries are from a canned fruit cocktail sold at the Dollar TreeIsland Choice Diced Fruit Cocktail (cherries have red #3).

Linnea Bullion | The Washington Post | Getty Images

The Food and Drug Administration said Wednesday it’s banning the use of Red No. 3, a synthetic dye that gives food and drinks their bright red cherry color but has been linked to cancer in animals.

The dye is still used in thousands of foods, including candy, cereals, cherries in fruit cocktails and strawberry-flavored milkshakes, according to the Center for Science in the Public Interest, a food safety advocacy group that petitioned the agency in 2022 to end its use.

The FDA’s decision marks a victory for consumer advocacy groups and some U.S. lawmakers who have long urged the FDA to revoke the additive’s approval, citing ample evidence that its use in beverages, dietary supplements, cereals and candies may cause cancer as well as affect children’s behavior. 

Food manufacturers will have until Jan. 15, 2027 to reformulate their products. Companies that make ingested drugs, such as dietary supplements, will get an additional year.

“The FDA cannot authorize a food additive or color additive if it has been found to cause cancer in human or animals,” Jim Jones, the FDA’s deputy director for human foods, said in a statement. “Evidence shows cancer in laboratory male rats exposed to high levels of FD&C Red No. 3.”

What is red dye No. 3? 

Red Dye No. 3, approved for use in foods in 1907, is made from petroleum. 

The FDA first became aware that the additive was possibly carcinogenic following a study in the 1980s that found tumors in male rats who were exposed to it in high doses. The agency banned the additive in cosmetics in 1990.

“It removes an unnecessary hazard from the American food supply, and we welcome that action, even though it should have occurred more than three decades ago, said Dr. Peter Lurie, president of the Center for Science in the Public Interest, a high-profile food industry watchdog group. 

Red No. 3 is already banned or severely restricted in places outside the U.S., including Australia, Japan and countries in the European Union.

Some U.S. food manufacturers have already removed artificial dyes, including Red No. 3, from their products. 

All color additives must be approved by the FDA before they are used in food sold in the U.S. There are 36 FDA-approved color additives, nine of which are synthetic dyes. 

The FDA has said it has been actively reviewing Red No. 3’s approval following a petition filed by a coalition of organizations, including the CSPI, asking the FDA to revoke the additive’s approval in foods, noting its potential cancer risks. 

There are also concerns about whether artificial food dyes might affect children’s behavior. The FDA in 2011 reviewed the possible link between artificial dyes and hyperactivity in children. It determined, however, that no causal relationship could be established. 

Although the FDA is now revoking its approval, ending its use nationwide, other states had already taken action.

California as well as 10 other states have already made moves to ban the food dye, according to CSPI.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More